Breast cancer treatment
1 – 10 of 235
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI) : a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study
(
- Contribution to journal › Article
-
Mark
Prognostic relevance of CD163+ immune cells in patients with metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
External validation of a multivariable prediction model for positive resection margins in breast-conserving surgery
(
- Contribution to journal › Article
-
Mark
Statin use and risk of breast cancer among women with benign breast disease : a Danish nationwide cohort study
2025) In British Journal of Cancer(
- Contribution to journal › Article
-
Mark
Enhancing the Prediction of Lymph Node Metastasis in Early Breast Cancer Using Deep Learning on Routine Full-Breast Mammograms
2025) In Breast Cancer Research(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Experiences of rehabilitation one year after breast cancer diagnosis-A focus group study from the ReScreen randomized controlled trial
(
- Contribution to journal › Article
-
Mark
Cancer rehabilitation in clinical practice : a qualitative study exploring contact nurses’ views on prerequisites
(
- Contribution to journal › Article
- 2024
-
Mark
G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the β1-adrenergic receptor, a membrane-associated guanylate kinase (MAGUK) scaffold protein, and protein kinase A anchoring protein (AKAP) 5 in MCF7 breast cancer cells
(
- Contribution to journal › Article
-
Mark
Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750)
(
- Contribution to journal › Article
-
Mark
Into the twilight zone – should ER-low breast cancer be treated as triple negative breast cancer?
(
- Contribution to journal › Debate/Note/Editorial